Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Sensorion
< Previous
1
2
3
Next >
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
April 26, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference
April 10, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025
April 08, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Availability of Its Letter to Shareholders
March 21, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Annual Bioprocessing Summit Europe
March 15, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Availability of its Financial Report for 2023
March 14, 2024
From
Sensorion
Via
Business Wire
Sensorion Reports Full-Year 2023 Financial Results and Business Update
March 14, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces it Has Met Primary Endpoint for SENS-401 Phase 2a Clinical Study for Residual Hearing Preservation
March 11, 2024
From
Sensorion
Via
Business Wire
Sensorion Will Host a Webcast on March 14, 2024, to Announce its 2023 Annual Financial Results
March 06, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Leerink Partners Global Biopharma Conference
February 29, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces a €50.5 Million Financing With Participation From New and Existing US and European Healthcare Specialist Investors
February 09, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces the Completion of Patient Inclusion in Phase 2a Clinical Trial of SENS-401 for Residual Hearing Preservation After Cochlear Implantation
February 01, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 47th Annual Midwinter Meeting
January 29, 2024
From
Sensorion
Via
Business Wire
Sensorion Appoints Dr. Federico Mingozzi as Non-Executive Director to the Board of Directors
January 25, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries
January 19, 2024
From
Sensorion
Via
Business Wire
Sensorion Announces Partnership With the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years
January 05, 2024
From
Sensorion
Via
Business Wire
Sensorion Publishes Results of Combined General Meeting Resolutions
December 21, 2023
From
Sensorion
Via
Business Wire
Sensorion Provides an Update on NOTOXIS, its Proof of Concept Phase 2a Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (CIO)
December 18, 2023
From
Sensorion
Via
Business Wire
Sensorion Appoints CMC Expert Bernd Schmidt as New Chief Technical Officer
December 12, 2023
From
Sensorion
Via
Business Wire
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of December 20, 2023
November 30, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces Its Attendance at the 42nd Annual J.P. Morgan Healthcare Meeting in San Francisco
November 23, 2023
From
Sensorion
Via
Business Wire
Sensorion to Participate in the Jefferies London Healthcare Conference and McDermott Will & Emery’s Life Sciences Symposium
October 25, 2023
From
Sensorion
Via
Business Wire
Sensorion Will Present At The European Society Of Gene & Cell Therapy (ESGCT) Conference
October 18, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces the Availability of Its Financial Report for the 1st Half of 2023
September 26, 2023
From
Sensorion
Via
Business Wire
Sensorion Announces Webconference on September 25, 2023, and its Participation in Upcoming Investor Conferences in October 2023
September 21, 2023
From
Sensorion
Via
Business Wire
Sensorion Reports 2023 First Half Results
September 20, 2023
From
Sensorion
Via
Business Wire
Sensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in Europe
July 19, 2023
From
Sensorion
Via
Business Wire
Sensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UK
July 10, 2023
From
Sensorion
Via
Business Wire
Sensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical Study
July 05, 2023
From
Sensorion
Via
Business Wire
Sensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical Study
June 19, 2023
From
Sensorion
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.